Table 1 Mean subject demographics and baseline characteristics (range)
From: Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects
Parameter | Intent to treat population N = 25 |
|---|---|
Age, years | 28.7 (18 - 54) |
Gender, males/females | 10/15 |
History of asthma, years | 15.3 (0 - 43) |
FEV1 % predicted | 92.8 (75.9 - 117.1) |
Methacholine PC20, mg/ml | 4.0 (0.3 - 14.4) |
Smokers | none |